TickerFacts.

A business in context

MRK research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-13 · 0000310158-26-000223

  2. 4 · Ownership change

    Report date 2026-08-12 · 0000310158-26-000221

  3. 4 · Ownership change

    Report date 2026-08-10 · 0000310158-26-000219

  4. 4 · Ownership change

    Report date 2026-08-06 · 0000310158-26-000217

  5. 4 · Ownership change

    Report date 2026-08-05 · 0000310158-26-000215

  6. 4 · Ownership change

    Report date 2026-08-05 · 0000310158-26-000214

  7. 4 · Ownership change

    Report date 2026-08-06 · 0000310158-26-000213

  8. 10-Q · Quarterly report

    Report date 2026-06-30 · 0000310158-26-000212

  9. 8-K · Current report

    Report date 2026-08-04 · 0001104659-26-090045 · Items 2.02,9.01

  10. 4 · Ownership change

    Report date 2026-06-30 · 0000310158-26-000202

  11. 8-K · Current report

    Report date 2026-05-26 · 0001104659-26-067509 · Items 5.07

  12. 8-K · Current report

    Report date 2026-05-22 · 0001628280-26-037738 · Items 8.01,9.01

  13. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001628280-26-029802

  14. 8-K · Current report

    Report date 2026-04-30 · 0001104659-26-052081 · Items 2.02,9.01

  15. DEF 14A · Proxy statement

    Report date 2026-05-26 · 0001193125-26-147704

  16. 10-K · Annual report

    Report date 2025-12-31 · 0000310158-26-000063

  17. 8-K · Current report

    Report date 2026-02-03 · 0001104659-26-009495 · Items 2.02,9.01

  18. 8-K · Current report

    Report date 2025-12-04 · 0001628280-25-055388 · Items 8.01,9.01

  19. 10-Q · Quarterly report

    Report date 2025-09-30 · 0000310158-25-000059

  20. 8-K · Current report

    Report date 2025-10-30 · 0001104659-25-103974 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2025-09-09 · 0000310158-25-000047 · Items 8.01,9.01

  22. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000310158-25-000014

  23. 8-K · Current report

    Report date 2025-07-25 · 0001104659-25-071380 · Items 2.02,2.05,9.01

  24. 8-K · Current report

    Report date 2025-05-27 · 0001104659-25-054131 · Items 5.07

  25. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001628280-25-021834

  26. 8-K · Current report

    Report date 2025-04-24 · 0001104659-25-038301 · Items 2.02,9.01

  27. DEF 14A · Proxy statement

    Report date 2025-05-27 · 0001193125-25-076859

  28. 10-K · Annual report

    Report date 2024-12-31 · 0001628280-25-007732

  29. 8-K · Current report

    Report date 2025-02-04 · 0001104659-25-008863 · Items 2.02,9.01

  30. 8-K · Current report

    Report date 2024-11-19 · 0001104659-24-122027 · Items 5.02,5.03,9.01

  31. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001628280-24-045689

  32. SC 13G/A · Ownership disclosure

    0000895345-24-000536

  33. 8-K · Current report

    Report date 2024-10-31 · 0001104659-24-112841 · Items 2.02,9.01

  34. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001628280-24-034715

  35. 8-K · Current report

    Report date 2024-07-30 · 0001104659-24-083722 · Items 2.02,9.01

  36. 8-K · Current report

    Report date 2024-05-28 · 0001628280-24-025800 · Items 5.07,8.01,9.01

  37. 10-Q · Quarterly report

    Report date 2024-03-31 · 0001628280-24-020283

  38. 8-K · Current report

    Report date 2024-04-25 · 0001104659-24-051517 · Items 2.02,9.01

  39. DEF 14A · Proxy statement

    Report date 2024-05-28 · 0001193125-24-093204

  40. 10-K/A · Annual report

    Report date 2023-12-31 · 0001193125-24-093194

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 40 transaction rows40AExercise / conversion: 30 transaction rows30MTax / exercise payment: 15 transaction rows15FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

85 matching transaction rows. Showing 1–50.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-05-29
2026-06-02
Warden Kathy JA · Grant / award
Acquired
Phantom Stock
Derivative security
1853.1118.72
2026-05-29
2026-06-02
Karsanbhai Surendralal LancaA · Grant / award
Acquired
Phantom Stock
Derivative security
1853.1118.72
2026-05-29
2026-06-02
Coe Mary EllenA · Grant / award
Acquired
Phantom Stock
Derivative security
1853.1118.72
2026-05-29
2026-06-02
THULIN INGE GA · Grant / award
Acquired
Phantom Stock
Derivative security
1853.1118.72
2026-05-29
2026-06-02
Seidman Christine EA · Grant / award
Acquired
Phantom Stock
Derivative security
1853.1118.72
2026-05-29
2026-06-02
RUSSO PATRICIA FA · Grant / award
Acquired
Phantom Stock
Derivative security
1853.1118.72
2026-05-29
2026-06-02
Rothman PaulA · Grant / award
Acquired
Phantom Stock
Derivative security
1853.1118.72
2026-05-29
2026-06-02
Mayo StephenA · Grant / award
Acquired
Phantom Stock
Derivative security
1853.1118.72
2026-05-29
2026-06-02
LAVIZZO-MOUREY RISA JA · Grant / award
Acquired
Phantom Stock
Derivative security
1853.1118.72
2026-05-29
2026-06-02
GLOCER THOMAS HA · Grant / award
Acquired
Phantom Stock
Derivative security
1853.1118.72
2026-05-29
2026-06-02
Craig Pamela J.A · Grant / award
Acquired
Phantom Stock
Derivative security
1853.1118.72
2026-05-29
2026-06-02
BAKER DOUGLAS M JRA · Grant / award
Acquired
Phantom Stock
Derivative security
1853.1118.72
2026-05-05
2026-05-07
Zachary JenniferA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
35312.00.0
2026-05-05
2026-05-07
Zachary JenniferA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
12064.00.0
2026-05-05
2026-05-07
Williams David MichaelA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
13582.00.0
2026-05-05
2026-05-07
Williams David MichaelA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
4640.00.0
2026-05-05
2026-05-07
Litchfield CarolineA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
46566.00.0
2026-05-05
2026-05-07
Litchfield CarolineA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
15908.00.0
2026-05-05
2026-05-07
Li Dean YA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
58207.00.0
2026-05-05
2026-05-07
Li Dean YA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
19885.00.0
2026-05-05
2026-05-07
Larson Betty DA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
23283.00.0
2026-05-05
2026-05-07
Larson Betty DA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
7954.00.0
2026-05-05
2026-05-07
DeLuca Richard R.A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
34924.00.0
2026-05-05
2026-05-07
DeLuca Richard R.A · Grant / award
Acquired
Restricted Stock Unit
Derivative security
11931.00.0
2026-05-05
2026-05-07
Davis Robert MA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
47724.00.0
2026-05-05
2026-05-07
Davis Robert MA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
139697.00.0
2026-05-05
2026-05-07
Foard BrianA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
31044.00.0
2026-05-05
2026-05-07
Foard BrianA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
35351.00.0
2026-05-05
2026-05-07
Foard BrianA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
10605.00.0
2026-05-05
2026-05-07
Maraldo David R.A · Grant / award
Acquired
Restricted Stock Unit
Derivative security
7424.00.0
2026-05-05
2026-05-07
Maraldo David R.A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
21731.00.0
2026-05-05
2026-05-07
Oosthuizen Johannes JacobusA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
10605.00.0
2026-05-05
2026-05-07
Oosthuizen Johannes JacobusA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
31044.00.0
2026-05-05
2026-05-07
Smart Dalton E. IIIA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
5045.00.0
2026-05-05
2026-05-07
Smart Dalton E. IIIA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
2298.00.0
2026-05-05
2026-05-07
Guindo ChirfiA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
6628.00.0
2026-05-05
2026-05-07
Guindo ChirfiA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
19402.00.0
2026-05-02
2026-05-05
Smart Dalton E. IIIM · Exercise / conversion
Acquired
Common Stock383.0112.16
2026-05-02
2026-05-05
Smart Dalton E. IIIF · Tax / exercise payment
Disposed
Common Stock132.0112.16
2026-05-02
2026-05-05
Smart Dalton E. IIIM · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
383.00.0
2026-05-02
2026-05-05
Maraldo David R.F · Tax / exercise payment
Disposed
Common Stock159.0112.16
2026-05-02
2026-05-05
Maraldo David R.M · Exercise / conversion
Acquired
Common Stock552.0112.16
2026-05-02
2026-05-05
Maraldo David R.M · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
552.00.0
2026-04-30
2026-05-01
Smart Dalton E. IIIF · Tax / exercise payment
Disposed
Common Stock159.0110.95
2026-04-30
2026-05-01
Smart Dalton E. IIIM · Exercise / conversion
Acquired
Common Stock464.0110.95
2026-04-30
2026-05-01
Smart Dalton E. IIIM · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
464.00.0
2026-04-30
2026-05-01
Larson Betty DM · Exercise / conversion
Acquired
Common Stock11350.0110.95
2026-04-30
2026-05-01
Larson Betty DF · Tax / exercise payment
Disposed
Common Stock5143.0110.95
2026-04-30
2026-05-01
Larson Betty DM · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
11350.00.0
2026-04-29
2026-05-01
Guindo ChirfiF · Tax / exercise payment
Disposed
Common Stock969.0110.03

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000310158Merck & Co., Inc.
Merck (Japan)MSD (Netherlands)Merck Sharp & Dohme (Switzerland)MSD Sharp & Dohme GmbHMerck Sharp & Dohme, UABMerck Sharp & Dohme Latvija, SIAMSD VACCINSMerck Sharp & Dohme B.V.MSD Norway ASMSD Czech Republic s.r.o.

Showing 10 of 10 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
4YV9Y5M8S0BRK1RP0397
GLEIF legal name
MERCK & CO., INC.
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2025-10-20T10:26:51Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Merck & Co. · alias · wikidata
  • Merck Sharp & Dohme Corp. · alias · wikidata
  • Merck (Japan) · subsidiary · wikidata
  • MSD (Netherlands) · subsidiary · wikidata
  • Merck Sharp & Dohme (Switzerland) · subsidiary · wikidata
  • Merck Sharp & Dohme · subsidiary · wikidata
  • MSD Sharp & Dohme GmbH · subsidiary · wikidata
  • MSD (Germany) · subsidiary · wikidata
  • MSD Sharp & Dohme Gesellschaft mit beschränkter Haftung · subsidiary · wikidata
  • Merck Sharp & Dohme (Germany) · subsidiary · wikidata
  • Merck Sharp & Dohme, UAB · subsidiary · wikidata
  • MSD Lithuania · subsidiary · wikidata
  • Merck Sharp & Dohme (Lithuania) · subsidiary · wikidata
  • Merck Sharp & Dohme Latvija, SIA · subsidiary · wikidata
  • MSD (Latvia) · subsidiary · wikidata
  • Merck Sharp & Dohme (Latvia) · subsidiary · wikidata
  • MSD VACCINS · subsidiary · wikidata
  • Merck Sharp & Dohme B.V. · subsidiary · wikidata
  • MSD Norway AS · subsidiary · wikidata
  • MSD (Norge) AS · subsidiary · wikidata
  • MSD Czech Republic s.r.o. · subsidiary · wikidata
  • MSD IT Global Innovation Center s.r.o. · subsidiary · wikidata
  • MSD IT Global Innovation Center · subsidiary · wikidata
  • MSD (Czech Republic) · subsidiary · wikidata
  • Merck Sharp & Dohme Czech Republic · subsidiary · wikidata
  • Merck & Co. Inc. · former SEC name · 2009-11-04 to 2014-12-09
  • SCHERING PLOUGH CORP · former SEC name · 1994-12-29 to 2009-10-29
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$64.17B$68.30B
2023-12-31$60.12B$65.87B
2022-12-31$59.28B$67.63B
2021-12-31$48.70B$60.01B
2020-12-31$41.52B$53.57B
2019-12-31$39.12B$51.09B
2018-12-31$42.29B$56.24B
2017-12-31$40.12B$54.66B

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗